Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I intrapulmonary pharmacokinetics of KRP-AM1977X (lascufloxacin) in healthy volunteers
jRCT2080222496Phase 1Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lascufloxacin, sponsored by Kyorin Pharmaceutical. Primary endpoints: Intrapulmonary concentration of AM-1977 in epithelial lining fluid, Intrapulmonary concentration of AM-1977 in alveolar macrophages and 2 more. Started May 2014; status: completed.
02
Drugs
lascufloxacin
Beyond the preview
Go deeper on jRCT2080222496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222496.